Is Jisandai (Bingtonsha) an antibiotic?
Epclusa is not an antibiotic. Jisandai (Bingtonsha) is an antiviral drug specifically used to treat hepatitis C virus (HCV) infection. It consists of two active ingredients, Sofosbuvir (Sofosbuvir) and Velpatasvir (Velpatasvir), which can inhibit and block the replication of hepatitis C virus, thereby helping to clear the virus from the body.
Antibiotics are a class of drugs used to treat bacterial infections. They treat infections caused by various bacteria, such as pneumonia, skin infections, urinary tract infections, etc., by killing or inhibiting the growth of bacteria. However, antibiotics are ineffective against viruses because their structures and biological mechanisms are very different from those of bacteria. This means antibiotics cannot be used to treat viral infections such as hepatitis C, HIV, influenza, etc.

Jisandai (Bingtonsha) works by targeting the replication process of hepatitis C virus. Specifically, sofosbuvir is a nucleotide polymerase inhibitor that can inhibit HCVRNApolymerase, thereby preventing viral replication. Velpatasvir is an NS5A inhibitor that can interfere with virus replication and assembly. These two ingredients work synergistically to make Bingtonsa effective in treating all genotypes of HCV infection.
Since Jisandai (Bingtonsa) is not an antibiotic, it is not used to treat bacterial infections. Therefore, if the patient also has a bacterial infection, antibiotic treatment may be required. Patients should be careful not to take antibiotics or other drugs by themselves while taking Jisandai (Bingtonsa), because some drugs may interact withJisandai (Bingtonsa), affecting the treatment effect or increasing the risk of side effects.
In general, Jisandai (Bingtonsa) is an antiviral drug that specifically targets the hepatitis C virus, not an antibiotic. It helps patients clear the hepatitis C virus by blocking its replication and is not used to treat bacterial infections. When using GISANDA (Bingtonsa) for treatment, patients should use other drugs under the guidance of a doctor to ensure the safety and effectiveness of the treatment.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)